Flow Diverting Stent Helps Contain Cerebrovascular Defects
By HospiMedica International staff writers Posted on 24 Jul 2018 |

Image: The Surpass Streamline Flow Diverter in proximity to an aneurysm (Photo courtesy of Stryker).
An innovative flow diverter embolization device protects susceptible patients from large and giant brain unruptured aneurysms.
The Stryker (Kalamazoo, MI, USA) Surpass Streamline Flow Diverter is a cobalt chromium braided stent that directs blood flow within an intracranial artery away from a weakened blood vessel sac or aneurysm. The high-mesh density of the braid is achieved by increasing the number of braid wires in concert with device diameter; while the 2 mm device has 48 braided wires, the 3 and 4 mm devices have 72 braided wires, and the 5 mm device has 96 wires, providing a more uniform pore density over different sizes.
Filament sizes change from 25 to 36 mm, depending on the device diameter. The increase in wires maintains consistent density across a range of vessel sizes, thereby facilitating reliable and consistent occlusion of the aneurysm over time, and helping to reduce the risk of a future rupture. In addition, the braid angle is designed to prevent unwanted changes in mesh density around curves and to minimize foreshortening. The Surpass Streamline Flow Diverter is loaded within a 3.7-Fr distal catheter with a pusher catheter and accepts a 0.014-inch micro-guidewire.
Surpass Streamline can be positioned using the Surpass delivery system, designed for consistent deployment; the Halo delivery system, which provides atraumatic access to distal vasculature using an intermediate catheter, improving stent fit and climbing performance; or the Streamline delivery system, which allows it to be repositioned distally or proximally, and to be redeployed until precise placement and enhanced vessel apposition are achieved.
“Surpass Streamline is the first flow diverter indicated for large and giant posterior communicating artery aneurysms; these unruptured aneurysms are more challenging, due to their location and surrounding anatomy,” said professor of radiology and neurological surgery Philip Meyers, MD, of New York Presbyterian/Columbia University Medical Center (NY, USA). “The stent is designed to reliably open and provide consistent mesh density across the neck of the aneurysm to aid in aneurysm occlusion while maintaining perforator artery patency.”
While originally indicated for wide-necked or fusiform aneurysms from the petrous segment to the clinoid segment of the internal carotid artery (ICA), flow diversion today is being more broadly applied to small aneurysms, anterior cerebral artery aneurysms, recurrent aneurysms, and other endoluminal and intra-saccular defects.
The Stryker (Kalamazoo, MI, USA) Surpass Streamline Flow Diverter is a cobalt chromium braided stent that directs blood flow within an intracranial artery away from a weakened blood vessel sac or aneurysm. The high-mesh density of the braid is achieved by increasing the number of braid wires in concert with device diameter; while the 2 mm device has 48 braided wires, the 3 and 4 mm devices have 72 braided wires, and the 5 mm device has 96 wires, providing a more uniform pore density over different sizes.
Filament sizes change from 25 to 36 mm, depending on the device diameter. The increase in wires maintains consistent density across a range of vessel sizes, thereby facilitating reliable and consistent occlusion of the aneurysm over time, and helping to reduce the risk of a future rupture. In addition, the braid angle is designed to prevent unwanted changes in mesh density around curves and to minimize foreshortening. The Surpass Streamline Flow Diverter is loaded within a 3.7-Fr distal catheter with a pusher catheter and accepts a 0.014-inch micro-guidewire.
Surpass Streamline can be positioned using the Surpass delivery system, designed for consistent deployment; the Halo delivery system, which provides atraumatic access to distal vasculature using an intermediate catheter, improving stent fit and climbing performance; or the Streamline delivery system, which allows it to be repositioned distally or proximally, and to be redeployed until precise placement and enhanced vessel apposition are achieved.
“Surpass Streamline is the first flow diverter indicated for large and giant posterior communicating artery aneurysms; these unruptured aneurysms are more challenging, due to their location and surrounding anatomy,” said professor of radiology and neurological surgery Philip Meyers, MD, of New York Presbyterian/Columbia University Medical Center (NY, USA). “The stent is designed to reliably open and provide consistent mesh density across the neck of the aneurysm to aid in aneurysm occlusion while maintaining perforator artery patency.”
While originally indicated for wide-necked or fusiform aneurysms from the petrous segment to the clinoid segment of the internal carotid artery (ICA), flow diversion today is being more broadly applied to small aneurysms, anterior cerebral artery aneurysms, recurrent aneurysms, and other endoluminal and intra-saccular defects.
Latest Surgical Techniques News
- First-Ever Technology Makes Blood Translucent During Surgery
- Tibia Nailing System with Novel Side-Specific Nails to Revolutionize Fracture Surgery
- New Imaging Probe to Transform Brain Cancer Surgery
- New Technology More Than Doubles Success Rate for Blood Clot Removal
- Surgical Ablation During CABG Improves Survival in Patients with Preexisting Atrial Fibrillation
- New Battery Technology Delivers Additional Power to Implantable Medical Devices
- New Model Reveals Optimal Positioning of Orthopedic Screws in Fractures
- Non-Invasive Tool for Removing Lung Cancer Tumors Reduces Surgical Trauma
- Advanced Imaging Endoscopes to Revolutionize Detection and Treatment of Gastrointestinal Disorders
- Novel Mechanical Heart Valve Improves Blood Flow and Lowers Risk of Blood Clots
- First-of-Its-Kind Device Replaces Mitral Valve Without Open-Heart Surgery
- Innovation in Thermographic Neurosurgical Imaging Supports Informed Decision-Making
- Fluorescent Soft Robots Accurately Locate Early Gastric Cancer During Laparoscopic Surgery
- Ultrasound-Activated Microstructures Clean Implanted Stents and Catheters
- First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment
- Bioprinted Aortas Offer New Hope for Vascular Repair
Channels
Critical Care
view channel
New System Measures Blood Sodium Without Needles
Accurately measuring blood sodium levels is crucial for diagnosing and managing various health conditions, including dehydration, kidney disease, and certain neurological and endocrine disorders.... Read more
Monitoring Airborne Fungal Spores Could Help Predict COVID-19 & Flu Surges
A new study presented at ASM Microbe 2025 has provided strong evidence that higher levels of fungal spores in the air are closely associated with spikes in influenza and COVID-19 cases. The findings suggest... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more